Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Eldacimibe (WAY-ACA-147) is an ACAT2 inhibitor for the treatment of cardiovascular disease and endocrine and metabolic disorders, study of atherosclerosis and hypercholesterolemia.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 146.00 | |
5 mg | In stock | $ 350.00 | |
10 mg | In stock | $ 530.00 | |
25 mg | In stock | $ 859.00 | |
50 mg | In stock | $ 1,180.00 | |
100 mg | In stock | $ 1,590.00 | |
500 mg | In stock | $ 3,190.00 |
Description | Eldacimibe (WAY-ACA-147) is an ACAT2 inhibitor for the treatment of cardiovascular disease and endocrine and metabolic disorders, study of atherosclerosis and hypercholesterolemia. |
Synonyms | WAY-ACA-147, UNII-4PBL76O2G8, ANA 147, ACA 147 |
Molecular Weight | 634.89 |
Formula | C39H58N2O5 |
CAS No. | 141993-70-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 50 mg/mL (78.75 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Eldacimibe 141993-70-6 Metabolism Acyltransferase ACA147 WAY-ACA 147 ACA-147 ANA-147 ANA147 WAY-ACA-147 WAY-ACA147 UNII-4PBL76O2G8 ANA 147 ACA 147 inhibitor inhibit